Invenomic Capital Management’s IRIDEX IRIX Stock Holding History

Invenomic Capital Management’s Portfolio IRIX Stock Details IRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-156,395	Closed	-$1.1M	–	134
2021 Q2	$1.1M	Sell	156,395 -2,650	-2%	-$20.1K	0.26%	77
2021 Q1	$1.07M	Sell	159,045 -341,772	-68%	-$1.97M	0.24%	74
2020 Q4	$1.26M	Buy	500,817 +59,407	+13%	+$112K	0.32%	65
2020 Q3	$866K	Buy	441,410 +31,126	+8%	+$64.4K	0.48%	70
2020 Q2	$869K	Hold	410,284	–	–	0.64%	55
2020 Q1	$660K	Buy	410,284 +461	+0.1%	+$1.19K	0.54%	63
2019 Q4	$918K	Buy	+409,823	New	+$866K	0.37%	81

Other funds holding IRIX

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $953M AUM 18.74% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Invenomic Capital Management's IRIX Position: Q3 2021 in Review

Invenomic Capital Management sold out of IRIDEX (IRIX) in Q3 2021, closing a stake of 156,395 shares — an estimated $1.1M sold.

Invenomic Capital Management first reported a position in IRIX in Q4 2019 and held it in 7 quarters. The position peaked at $1.26M in Q4 2020. 29 funds tracked by Wall St. Rank hold IRIX as of Q3 2021.

Invenomic Capital Management reported no remaining IRIDEX position as of Q3 2021 after selling out during the quarter.
Invenomic Capital Management sold 156,395 IRIDEX shares in Q3 2021, an estimated $1.1M.
Invenomic Capital Management first reported a position in IRIDEX in Q4 2019 and held it in 7 quarters.
Invenomic Capital Management's IRIDEX position peaked at $1.26M in Q4 2020.
29 funds tracked by Wall St. Rank held IRIDEX as of Q3 2021.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.